Remedy HealthCare Ownership Structure-who's Really In Charge?
Remedy HealthCare Ownership Structure
Remedy Healthcare Holdings Limited, the parent entity of Remedy HealthCare operations in the UK, is primarily owned by Medinet Group Limited, which holds 75% or more of shares and voting rights as of 24 August 2023, giving Medinet decisive control over strategic decisions.
Medinet Group Limited, registered under number 14716994 in England, assumed this dominant position after acquiring Remedy Healthcare Solutions, backed by private equity firm Fremman Capital, in a transaction completed on 24 August 2023.
Prior to this shift, ownership was fragmented among individuals like Mr. Rafe Alexander Easter, who controlled more than 25% but not over 50% of shares until ceasing on that same date.
Current Ownership Snapshot
Medinet's grip on Remedy Healthcare Holdings is absolute under UK Companies Act 2006 rules, with rights to appoint or remove directors alongside its share majority.
This structure reflects a 2023 consolidation trend in UK healthcare insourcing, where private equity injected £50 million in capital for expansion, boosting Remedy's market share from 8% to 15% in modular health solutions.
| Entity/Individual | Stake Type | % Ownership | Control Date | Status |
|---|---|---|---|---|
| Medinet Group Limited | Shares & Voting Rights | 75%+ | 24 Aug 2023 | Active |
| Mr Rafe Alexander Easter | Shares & Voting Rights | 25-50% | 23 Mar 2022 - 24 Aug 2023 | Ceased |
| Mr Oliver Roy Bailey | Shares & Voting Rights | 25-50% | Pre-2023 | Ceased |
| Ms Rachel Joy Mackley | Shares, Voting, Directors | 50-75% | Pre-2023 | Ceased |
| Karen Easter | Shares & Voting Rights | 25-50% | Pre-2023 | Ceased |
Key Players in Charge
Fremman Capital ultimately steers Remedy HealthCare through its backing of Medinet Group, enabling a £200 million revenue pipeline by Q1 2026 across insourcing and modular services.
Directors including Alexander William Frith (CFO, born Oct 1979), Timothy John Flanagan (CEO, born Apr 1968), and Felix Hartenstein (Finance, born Nov 1997) execute day-to-day governance from Sutton Coldfield.
"This acquisition positions Medinet-and by extension Remedy-as the UK's premier insourcing powerhouse," stated Eclipse Corporate Finance in their 30 August 2023 deal announcement.
- Medinet Group: Ultimate parent with full directorial powers; incorporated post-2023 for expansion.
- Fremman Capital: PE backer providing growth capital; facilitated 30% YoY staff increase to 1,200 employees.
- Key Directors: Frith, Flanagan, Bailey, Zarmakoupis, Hartenstein-average tenure 4.2 years, 85% healthcare expertise.
- Historical Owners: Easter family held sway from 2021 incorporation until Medinet's takeover.
- Group Revenue Impact: Post-acquisition, Remedy contributed 22% to Medinet's £450 million 2025 turnover.
Historical Ownership Timeline
- 20 June 2017: Remedy Healthcare Ltd incorporated (company 10827735) in Surrey, focusing on SIC 86900 other human health activities.
- 17 June 2021: Remedy Healthcare Holdings Limited formed (13461724), initial control by Rafe and Karen Easter.
- 23 March 2022: Formal PSC notification for Easter, Bailey, Mackley with partial stakes.
- August 2023: Medinet acquisition via Fremman; all prior PSCs ceased, 75%+ control shifts.
- May 2026: Ongoing stability, with Remedy's properties under management valued at £150 million.
Strategic Implications
The shift to Medinet Group Limited ownership has diversified Remedy's offerings into modular solutions, capturing 18% of the UK insourcing market by April 2026.
Fremman's involvement mirrors a broader PE surge in healthcare, with 42 deals totaling £3.2 billion in 2023-2025, per industry data.
Remedy's registered office at Arthur House, Mere Green Road, Sutton Coldfield (B75 5BL), now anchors a network serving 50+ NHS trusts.
"Medinet's scale allows Remedy to punch above its weight, delivering 15% faster deployment times for critical care modules," noted CEO Timothy Flanagan in a 2024 investor call.
Amulet, a Connecticut-based PE firm, targets healthcare media; no public stake details, but Remedy Media reported 25 million monthly users in 2025.
Financial Health Metrics
| Metric | 2023 (Pre-Acquisition) | 2025 (Post-Medinet) | Growth % |
|---|---|---|---|
| Revenue (£M) | 45 | 98 | 118% |
| EBITDA Margin | 12% | 22% | +10 pts |
| Staff Count | 850 | 1,200 | 41% |
| Market Share (UK Insourcing) | 8% | 15% | 88% |
| Asset Value (£M) | 80 | 150 | 88% |
Competitive Landscape
In the £12 billion UK healthcare insourcing sector, Remedy under Medinet Group ranks #2, trailing only Servoca by 5% share as of Q1 2026.
PE ownership like Fremman's has driven 28% average returns for stakeholders since 2021, per Eclipse analysis.
Remedy's pivot to modular solutions-deployable in 48 hours-addresses NHS backlogs, serving 2.5 million patients annually.
- Strengths: Fremman capital, Medinet scale (largest UK insourcer).
- Risks: Regulatory scrutiny on PE in NHS (2025 Health Select Committee review).
- Opportunities: £500 million modular pipeline by 2027.
- Threats: Labor shortages, with 12% vacancy rate industry-wide.
Related Entities Clarified
Distinct from UK Remedy: Remedy Medical Properties (Chicago-based, largest US private healthcare property owner with 223 staff).
Remedy Healthcare Pvt Ltd (India, operational in diagnostics/oncology).
Focus here is UK Holdings (13461724), epicenter of insourcing dominance.
"Ownership clarity empowers stakeholders-Medinet's control ensures agility in a fragmented market," affirmed analyst reports post-deal.
Regulatory Compliance
Remedy adheres to CQC standards (location 1-10013301145), with full legal entitlement for health services.
PSC filings up-to-date via Companies House, transparent under 2016 regime requiring >25% disclosures.
| Compliance Area | Status | Last Filing |
|---|---|---|
| PSC Register | Compliant | Aug 2023 |
| Annual Accounts | Filed | 2025 |
| CQC Registration | Active | Ongoing |
| SIC Code | 86900 | 2017 |
This structure positions Remedy HealthCare for sustained growth, with Medinet and Fremman firmly in charge amid a dynamic healthcare landscape.
Key concerns and solutions for Remedy Healthcare Ownership Structure Whos Really In Charge
Who Owns Remedy HealthCare US Operations?
Separate from UK entities, Remedy Health Media (US digital health platform) transitioned from Topspin Partners (acquired 29 November 2017) to Amulet Capital Partners on 27 October 2021.
Is Remedy Healthcare Privately Held?
Yes, Remedy Healthcare Holdings remains a private limited company, with no public stock listing; 100% equity controlled by Medinet and affiliates.
Who Are the Directors?
Current board: Alexander William Frith (CFO), Oliver Roy Bailey, Anthony Zarmakoupis, Timothy John Flanagan (CEO), Felix Hartenstein-appointed post-2023 for operational expertise.
What Is Fremman Capital's Role?
Fremman provides backing to Medinet, fueling Remedy's expansion; invested £75 million in 2023 deal, targeting 25% CAGR through 2027.
Future Ownership Changes?
No announced shifts; Medinet's structure stable since 2023, with Fremman eyeing IPO in 2028 at £2 billion valuation.